WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
SHANGHAI, April 28 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the first quarter of...
WuXi PharmaTech Files 2009 Annual Report on Form 20-F
SHANGHAI, April 24 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at ht...
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results
SHANGHAI, China, March 9 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial r...
WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
SHANGHAI, March 2 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with Johnson & Joh...
WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
SHANGHAI, China, Feb. 24 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that it received the formal certificate of GMP compl...
WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
SHANGHAI, Feb. 18 /PRNewswire-Asia-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quar...
WuXi AppTec and QIAGEN Enter into Partnership Agreement for Molecular Biomarker Development
SHANGHAI, Jan. 11 /PRNewswire-Asia/ -- WuXi AppTec Inc. today announced that it has entered into a partnership with QIAGEN to provide an integrated single solution for molecular biomarker development, validation and personalized healthcare targets to their respective client bases. QIAGEN will pr...
WuXi PharmaTech to Present at 28th Annual J.P. Morgan Healthcare Conference
SHANGHAI, China, Jan. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Dr. Ge Li, the Company's Chairman a...
WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
SHANGHAI, Dec. 22 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, announced that it had been selected for the Deloitte Technology Fast 500 As...
WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening
SHANGHAI, Dec. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today it has purchased a Labcyte POD(TM) 810 plate assembler equippe...
WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, announced that it had been selected to the Deloitte Technology Fast 50 China...
WuXi PharmaTech Announces Third-Quarter 2009 Results
SHANGHAI, Nov. 17 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial re...
WuXi AppTec Receives 2009 Schering-Plough Excellence Award
SHANGHAI, Oct. 30 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company, with operations in China and the United States, today announced that it had received the 2009 Excellence Aw...
WuXi PharmaTech Schedules Third-Quarter 2009 Earnings Release
SHANGHAI, Oct. 28 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter of 20...
WuXi PharmaTech Appoints Dr. Hui Cai as Vice President of Business Development
SHANGHAI, Oct. 22 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Dr. Hui Cai has been appointed as Vice Pr...
WuXi PharmaTech to Participate in Upcoming Investor Conferences
SHANGHAI, Sept. 10 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that Dr. Ge Li, the Company’s Chairman and Chief Executive Officer, will participate at the Morgan Stanley Global Healthcare Unplugged Conference in New York on Tuesday, September 15, 2009, at 11:3...
WuXi PharmaTech Selected as One of the Top Ten Employer for New College Graduates in Pharmaceutical Industry in 2009
SHANGHAI, Aug. 14 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company, with operations in China and the United States, today announced that it had been selected as one of the top t...
WuXi PharmaTech Announces Second-Quarter 2009 Results
SHANGHAI, Aug. 12 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial result...
WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting
SHANGHAI, Aug. 10 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on August 7, 2009. (Logo: http://www.prnasia.com/sa/2009/04/01/200904011147.jpg ) At ...
WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology
SHANGHAI, July 23 /PRNewswire-Asia/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Dr. Chi-Chung Chan has been appointed as...
